Hydroxylation and glucosidation of ent-16β-Hydroxybeyeran-19-oic acid by Bacillus megaterium and Aspergillus niger

Li Ming Yang, Feng-Lin Hsu, Juei Tang Cheng, Cheng Hao Chang, Pan Chun Liu, Shwu Jiuan Lin

研究成果: 雜誌貢獻文章同行評審

16 引文 斯高帕斯(Scopus)

摘要

ent-16β-Hydroxybeyeran-19-oic acid (1) has potential antihypertensive activity. To obtain novel and more-effective compounds, 1 was incubated with Bacillus megaterium ATCC 14581 and Aspergillus niger CCRC 32720. The structures of the metabolites were determined by HR-FAB-MS, 1D- and 2D-NMR spectral data, and enzymatic hydrolysis. Bacillus megaterium hydroxylated and glucosidated 1 to yield ent-7α,16β-dihydroxybeyeran-19-oic acid (2), ent-16β-hydroxybeyeran-19-oic acid α-D-glucopyranosyl ester (3), and ent-7α,16β-dihydroxybeyeran-19-oic acid α-D-glucopyranosyl ester (4). Aspergillus niger hydroxylated 1 to yield ent-1β,7α, 16β-trihydroxybeyeran-19-oic acid (5) and ent-1β,7α-dihydroxy- 16-oxobeyeran-19-oic acid (6). Metabolites 3-5 were characterized as new compounds. In addition, 2, 3, 5, and 6 were tested for antihypertensive effects, and we found that 5 and 6 were more potent than the parent compound 1.
原文英語
頁(從 - 到)359-363
頁數5
期刊Planta Medica
70
發行號4
DOIs
出版狀態已發佈 - 四月 2004

ASJC Scopus subject areas

  • Plant Science
  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

指紋 深入研究「Hydroxylation and glucosidation of ent-16β-Hydroxybeyeran-19-oic acid by Bacillus megaterium and Aspergillus niger」主題。共同形成了獨特的指紋。

引用此